Bioavailability and Pharmacokinetics of Anisatin in Mouse Blood by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry

Abstract EN

Background.

Anisatin is a neurotoxic sesquiterpene dilactone wildly found in plants of the family Illiciaceae.

Due to morphological similarities among Illiciaceae fruits, fatal poisonings are frequent.

Objective.

This study is aimed at developing a rapid, simple ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method to determine anisatin’s bioavailability in mouse blood and the method’s application to pharmacokinetics.

Methods.

Blood samples were preprocessed by protein precipitation using acetonitrile.

Salicin (internal standard, IS) and anisatin were gradient-eluted by a mobile phase of methanol and water (0.1% formic acid) in a UPLC BEH C18 column.

This step involved using an electrospray ionization source of anisatin at a mass-to-charge ratio (m/z) of 327.1→127.0 and IS at m/z 285.1→122.9 in the negative ion mode with multiple reaction monitoring.

Results.

The calibration curve ranged from 1 to 2000 ng/ml (r>0.995), with the method’s accuracy ranging from 86.3% to 106.9%.

Intraday and interday precision were lower than 14%, and the matrix effect was between 93.9% and 103.3%.

The recovery rate was higher than 67.2%.

Conclusions.

The developed UPLC-MS/MS method was successfully used for a pharmacokinetic study of oral (1 mg/kg) and intravenous (0.5 mg/kg) administration of anisatin to mice—the absolute bioavailability of anisatin in the mouse blood was 22.6%.